222 related articles for article (PubMed ID: 29336772)
1. tPA/DNase for Complicated Parapneumonic Effusions and Empyemas.
Maiga A; Pinkerman R; Deppen SA; Scruggs J; Mcguire P; Tarpley JL; Grogan EL
Am Surg; 2017 Dec; 83(12):1458-1459. PubMed ID: 29336772
[No Abstract] [Full Text] [Related]
2. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
5. Emerging concepts in pleural infection.
Chan KP; Fitzgerald DB; Lee YCG
Curr Opin Pulm Med; 2018 Jul; 24(4):367-373. PubMed ID: 29538080
[TBL] [Abstract][Full Text] [Related]
6. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.
Schiza SE; Antoniou KM; Economidou FN; Siafakas NM
Pulm Pharmacol Ther; 2005; 18(6):381-9. PubMed ID: 15998594
[TBL] [Abstract][Full Text] [Related]
8. Point: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? Yes.
Corcoran JP; Rahman NM
Chest; 2014 Jan; 145(1):14-17. PubMed ID: 24394816
[No Abstract] [Full Text] [Related]
9. Mixing It Up: Coadministration of tPA/DNase in Complicated Parapneumonic Pleural Effusions and Empyema.
Bishwakarma R; Shah S; Frank L; Zhang W; Sharma G; Nishi SP
J Bronchology Interv Pulmonol; 2017 Jan; 24(1):40-47. PubMed ID: 27984384
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural tissue plasminogen activator for complicated pleural effusions.
Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
J Trauma; 2004 Dec; 57(6):1178-83. PubMed ID: 15625447
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator and DNase in empyema.
Simons SO; Smits D; van der Heijden E
N Engl J Med; 2011 Nov; 365(20):1936; author reply 1936-7. PubMed ID: 22087692
[No Abstract] [Full Text] [Related]
12. Tissue plasminogen activator and DNase in empyema.
Bachmayer K
N Engl J Med; 2011 Nov; 365(20):1936; author reply 1936-7. PubMed ID: 22087691
[No Abstract] [Full Text] [Related]
13. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive treatment of complicated parapneumonic effusions and empyemas in adults.
Porcel JM
Clin Respir J; 2018 Apr; 12(4):1361-1366. PubMed ID: 29087029
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
[TBL] [Abstract][Full Text] [Related]
16. Treatment of complicated empyema--perspectives on perspective.
Rubenstein JS
Pediatr Crit Care Med; 2003 Jan; 4(1):122-3. PubMed ID: 12656561
[No Abstract] [Full Text] [Related]
17. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions.
Chin NK; Lim TK
Chest; 1997 Feb; 111(2):275-9. PubMed ID: 9041968
[TBL] [Abstract][Full Text] [Related]
18. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
[TBL] [Abstract][Full Text] [Related]
19. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
[TBL] [Abstract][Full Text] [Related]
20. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
Yokoyama Y; Kuno T; Takagi H; Burfeind W
Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
